Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Weight Care at Alloy Were here to help you feel amazing in your body, inside and out
In Phase 2 trials, retatrutide's highest dose group (12 mg) produced a mean body weight reduction of 24.2% at 48 weeks, compared to approximately 22.5% for tirzepatide's highest dose in its own trials
The single most important distinction the trending search misses: a topical peptide serum sold over the counter and an injectable peptide protocol prescribed and supervised by a medical clinic are not the same product, do not deliver the same dose, and do not produce the same clinical outcome
Regulatory status and what comes next As of the date of publication, CagriSema has not received regulatory approval from any major health authority, including the MHRA (UK), EMA (Europe), or FDA (United States)
